Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis - Wikidata - wikimedia - TriplyDB

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

http://www.wikidata.org/entity/Q34737721

about

Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis Understanding the role of B cells in atherosclerosis: potential clinical implications The influence of innate and adaptive immune responses on atherosclerosis Fcγ Receptors in Solid Organ Transplantation Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity Generation and biological activities of oxidized phospholipids Effects of mobile phone use on brain tissue from the rat and a possible protective role of vitamin C - a preliminary study Immunity, atherosclerosis and cardiovascular disease CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide B cells and atherosclerosis.Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.B cell subsets in atherosclerosis.Clinical significance of the humoral immune response to modified LDL.Vaccine against arteriosclerosis: an update.Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study.Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease Immunomodulation of vascular diseases: atherosclerosis and autoimmunity B cells and humoral immunity in atherosclerosis Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.Immunomodulation of atherosclerosis: myth and reality.Autoimmunity in atherosclerosis: lessons from experimental models.Immune recognition of OxLDL in atherosclerosis.Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.Anti-inflammatory therapies for cardiovascular disease Antigen-specific immune reactions to ischemic stroke.Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine Atherosclerosis and autoimmunity.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.A journey in science: medical scientist in translation.4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes.Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) mice Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice Atherosclerotic plaque formation and risk factors.Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.

P2860

Q26822962-58A10B83-FC8B-4BD4-A607-CD9C982F811C Q26828643-C6A237C8-959B-4452-9DE9-422C4CC88FE0 Q26991813-544E1C69-FF89-4524-8C8F-80D3F70E48B9 Q27000370-46C68DFA-6D93-4660-B2B8-0307CA72A423 Q28076012-184CE0DE-D182-4888-9847-850DA92F30E1 Q28344371-64C9E951-7D92-4D26-801E-10360459AE2C Q28389691-98E19636-7BB2-47C1-BFA9-044B7CA9E281 Q28583247-755EA877-12BC-4174-B010-FD18FE550386 Q28688590-E163C953-9E10-4015-99D7-B1B5CEE5F825 Q28732168-1BEFD08C-9A11-4FDD-B93C-B30F7D379A23 Q30252928-B326B830-8A00-46EB-BBF1-99B9F861B58A Q30413616-8F63CA6F-EBDF-4810-9758-79FA792B14D7 Q30423324-E9477DD2-4EB2-49EE-9427-CB9772AEDE84 Q33598770-8F09B98A-686D-4899-882A-0ACE88ED128F Q33641227-D3BDDB1B-E8B4-4D2F-9780-8C66220D4493 Q33663533-56BA1724-825E-41AB-AAB3-8E9C0CF42BD2 Q33739644-C7B2B6C3-79FB-4562-AD96-9B7C8DECFAF7 Q33770999-C182A5C1-098A-4A24-9E77-F283AFD75739 Q33789638-2F9052D6-6D48-4A19-82AE-21DE44197705 Q33805176-5DC68F22-796D-41EE-B86A-B90799735F4D Q33834184-3675B673-A692-457E-96DF-8E8173FF445D Q33890414-60F843B5-59DF-4929-9C42-27E9BEC74238 Q33915478-99DAC55A-97CD-4FF9-98AE-52F9001961BA Q33947786-8C673FC1-05F8-4973-A410-E5619312CDB0 Q34082315-C69C2529-DB32-48D0-B600-D1AE3D0E895B Q34137872-3C898F68-0715-4006-8829-655F182C7080 Q34171339-E60CB7F2-F6F8-4B67-9616-1B5A1154A83B Q34238712-CB91440A-7499-491F-8D70-997BD0BA9438 Q34243799-07AD04BB-2C15-4F3C-9F1F-3585F7A11616 Q34350546-747440B6-8C3B-4113-BFAC-D87B7775D300 Q34416243-1F946989-F2AA-4A9C-AB40-B1A383EEB179 Q34421798-B1FE63F2-2B32-44EF-B29A-A9B8091B30EC Q34428867-26360654-3692-42E0-A993-A3A5365991E6 Q34578952-81F2B122-6920-45DD-AD0A-C0A77B681FEB Q34644753-B5E56CA0-6E4F-49C0-9F8E-B8D8BC4C9CF4 Q34789613-0D657302-E3B9-4864-90E6-653B9701E1A8 Q34804388-CB5C3C31-83E6-4FB6-A4C3-8E90F8694F36 Q35023076-1D53B0B7-ECDF-43FA-B5F1-B45396D106C1 Q35063770-99FA7558-3E69-4769-9CCC-DE64A9BFAC24 Q35174901-3FE407ED-F9FC-4544-AA64-4F1F3D477D42

P2860

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

http://www.wikidata.org/entity/Q34737721

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Immunization of low density li ...... fied LDL reduces atherogenesis

@ast

Immunization of low density li ...... fied LDL reduces atherogenesis

@en

Immunization of low density lipoprotein

@nl

type

label

Immunization of low density li ...... fied LDL reduces atherogenesis

@ast

Immunization of low density li ...... fied LDL reduces atherogenesis

@en

Immunization of low density lipoprotein

@nl

prefLabel

Immunization of low density li ...... fied LDL reduces atherogenesis

@ast

Immunization of low density li ...... fied LDL reduces atherogenesis

@en

Immunization of low density lipoprotein

@nl

P1433

Q34737721-9DA0B765-F216-4331-8487-4D554A66EF8D

P1476

Q34737721-B0386ED7-79D9-4106-825A-5930577ABBDC

P2093

Q34737721-0DFAE45F-86D4-4B8E-94C0-C230896DCB91

Q34737721-298AE820-EF1A-4B00-A59F-86FF1C6C077C

Q34737721-82A6B5B2-054F-4FE5-B857-7E79A5EDAA28

P2860

Q34737721-044BDEA5-A2F4-4C66-9A78-45BA08329794

Q34737721-083CE959-B257-4134-939A-76943B12F9B8

Q34737721-27D339E2-8192-44A6-BFA8-5F329F460126

Q34737721-2FAC33AA-21AB-4F3B-93F6-3AB12F2EC847

Q34737721-3F9A68E9-EC57-4749-836A-0201FC26D683

Q34737721-446F148A-2FE8-465C-AD35-50622BAA0A8A

Q34737721-44FE6B09-42CB-41F2-9A55-45E301309862

Q34737721-51EAFA6C-7FEB-4725-8AEC-B9914B4803B2

Q34737721-5282671F-A48D-41DC-985D-881242075A73

Q34737721-6DE632F1-E501-4E16-9F1A-C365227AD7AD

P304

Q34737721-8384FB67-3EEB-4BC3-A689-740EFD4B93A7

P31

Q34737721-DAFE964B-F5B9-409C-8FF8-F7ACC920C4C2

P356

Q34737721-3921642A-69EC-4419-A11A-3368D6A024A5

P407

Q34737721-87878389-1D53-442B-8E62-6312877570FA

P433

Q34737721-982C6CC8-4859-45E0-8BBF-F001318BA1C9

P478

Q34737721-3ABC5FE9-154A-4723-AE77-3F76BA2871FE

P577

Q34737721-0B5D4398-DF3D-4D57-9DCE-2341E4978571

P5875

Q34737721-9930FA3E-8F41-478B-B9F6-E1236483E1D7

P698

Q34737721-6F5A9AEA-03EC-4BBB-B144-83F08FE67056

P921

Q34737721-1516FF31-1EC8-47F0-8DE9-40574C4694BF

Q34737721-A4BFDB07-FD57-46DE-912D-FAC8E728BAD1

P932

Q34737721-FB631EDB-A9DE-4F4D-9125-5A7D575B0563

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunization of low density li ...... fied LDL reduces atherogenesis

@en

P2093

E Miller

http://www.w3.org/2001/XMLSchema#string

J L Witztum

http://www.w3.org/2001/XMLSchema#string

W Palinski

http://www.w3.org/2001/XMLSchema#string

P2860

Low density lipoprotein undergoes oxidative modification in vivo.

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis

Hypercholesterolemia increases endothelial superoxide anion production

Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet

Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.

Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig.

T lymphocytes inhibit the vascular response to injury.

Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

P304

821-825

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.3.821

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15353284

http://www.w3.org/2001/XMLSchema#string

P698

7846059

http://www.w3.org/2001/XMLSchema#string

P921

P932

42712

http://www.w3.org/2001/XMLSchema#string